Life sciences consultancy Indegene acquired market access consultancy Medical Marketing Economics (MME) for $ 10 million, with the aim of strengthening its biopharmaceutical pricing and reimbursement capabilities.
MME and its team of 40 people, split between Montclair, NJ, and Oxford, MS, will continue to operate as a stand-alone company. A source confirmed that the company plans to hire additional talent.
“MME brings a proven PRMA [pricing, reimbursement and market-access] capabilities that complement our co-marketing solution, ”said Manish Gupta, co-founder and CEO of Indeedene, in a statement.
Jack Mycka, President and Global CEO of MME, will report to Ingene Co-Founder and Executive Vice President Gaurav Kapoor, based in Princeton, New Jersey.
The purchase marks Ingene’s first acquisition since raising $ 200 million from private equity firms Carlyle Group and Brighton Park Capital this year. In view of this capital injection, Indegene plans to continue expanding through acquisitions “in the coming months,” Gupta said in a recent interview.
Indigene’s previous acquisitions have included UK-based DT Associates specializing in digital transformation and customer experience.